<DOC>
	<DOCNO>NCT02111434</DOCNO>
	<brief_summary>The study design answer follow question : 1 . What level visceral adiposity index Triglycerides/HDL cholesterol ratio hypogonadism ? 2 . What effect testosterone replacement visceral adiposity index Triglycerides/HDL cholesterol ratio ?</brief_summary>
	<brief_title>Visceral Adiposity Index Triglyceride/High-density Lipoprotein Cholesterol Ratio Congenital Hypogonadotropic Hypogonadism Effect Testosteron Treatment</brief_title>
	<detailed_description>This retrospective design , perform investigating registration patient hypogonadotrophic hypogonadism year 2007-2010 .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Men Congenital hypogonadism Treatment Naive Previous history androgen replacement Hypertension Diabetes mellitus</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>visceral adiposity index</keyword>
	<keyword>triglyceride / hdl cholesterol ratio</keyword>
	<keyword>testosterone</keyword>
</DOC>